Orange Book product · Generic (ANDA)
FENOFIBRATE (MICRONIZED)
FENOFIBRATE
At a glance
Oct 19, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 19, 2020
5 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
FENOFIBRATE
Strength
67MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 213842
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FENOFIBRATE
- 2013ANTARA (MICRONIZED)Brand (NDA)
NDA 021695 · LUPIN
- 2006LIPOFENBrand (NDA)
NDA 021612 · CIPHER PHARMS INC
- 1993LIPIDILBrand (NDA)
NDA 019304 · ABBVIE
- 2026FENOFIBRATEGeneric (ANDA)
ANDA 210379 · MACLEODS PHARMS LTD
- 2024FENOFIBRATEGeneric (ANDA)
ANDA 210248 · MACLEODS PHARMS LTD
- 2024FENOFIBRATEGeneric (ANDA)
ANDA 218548 · YICHANG HUMANWELL
- 2024FENOFIBRATE (MICRONIZED)Generic (ANDA)
ANDA 211407 · CHARTWELL
- 2023FENOFIBRATEGeneric (ANDA)
ANDA 217732 · CREEKWOOD PHARMS
- 2022FENOFIBRATEGeneric (ANDA)
ANDA 216798 · AUROBINDO PHARMA
- 2021FENOFIBRATE (MICRONIZED)Generic (ANDA)
ANDA 212232 · AUROBINDO PHARMA LTD
- 2021FENOFIBRATEGeneric (ANDA)
ANDA 208476 · BOSTAL
- 2020FENOFIBRATEGeneric (ANDA)
ANDA 213864 · MANKIND PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
